Document Type : Case Reports

Authors

1 Department of Pathology, Imam Khomeini Hospital, Mazandaran University of Medical Sciences, Sari, Iran

2 Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran

3 Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

10.30699/ijp.2020.120698.2411

Abstract

Dendritic cells (DCs) are key arms of immune system, which act in antigen presenting processes, and are considered as a bridge between innate and adaptive immune responses. DCs are found in both lymphoid and non-lymphoid organs. They are called interdigitating dendritic cells (IDCs) in secondary lymphoid organs. IDCs lack lineage surface markers and are positive for S-100 and vimentin. IDC sarcoma (IDCS) is a very rare neoplasm, which mainly affects lymph nodes, though there are reports of extra-nodal involvement. IDCS is thought to have poor prognosis. Although there is no consensus on the treatment modalities, such options as radicalsurgery, chemotherapy, and radiotherapy are performed depending on severity and site of the lesion. In this study, we present a case of IDCS in a 53-year-old male with a history of several skin lesions and prior diagnoses of basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and metatypical carcinoma (MTC).

Keywords

Main Subjects

Zhu J, Su S, Zhou J, Li H. Interdigitating dendritic cell sarcoma presenting in the sigmoid colon mesentery: A case report and literature review. Medicine (Baltimore). 2017;96(16):e6210. [DOI:10.1097/MD.0000000000006210] [PMID] [PMCID]

Shi F, Song Q, Wang L, Gao Y, Chang H. Diffuse lesion and necrosis tied to poorer prognosis of interdigitating dendritic cell sarcoma: cases report and a pooled analysis. Sci Reports. 2017;7(1):667. [DOI:10.1038/s41598-017-00719-2] [PMID] [PMCID]

Xue T, Jiang XN, Wang WG, Zhou XY, Li XQ. Interdigitating dendritic cell sarcoma: Clinicopathologic study of 8 cases with review of the literature. Ann Diagn Pathol. 2018;34:155-60. [DOI:10.1016/j.anndiagpath.2018.03.008] [PMID]

Chang KL, Arber DA, Weiss LM. Lymph Nodes. In: Weidner N, Cote RJ, Suster S, Weiss LM, editors. Modern Surgical Pathology. Philadelphia: W.B. Saunders; 2009. p. 1431-511. [DOI:10.1016/B978-1-4160-3966-2.00041-2]

Kyogoku C, Seki M, Ogawa S, Miyamoto K, Ito Y, Kurita N, et al. Complete Remission in Systemic Skin Interdigitating Dendritic Cell Sarcoma after ABVD Chemotherapy. J Clin Exp Hematop. 2015;55(1):33-7. [DOI:10.3960/jslrt.55.33] [PMID]

Chen H-Z, Bonneville R, Yu L, Wing MR, Reeser JW, Krook MA, et al. Genomic characterization of metastatic ultra-hypermutated interdigitating dendritic cell sarcoma through rapid research autopsy. Oncotarget. 2019;10(3):277. [DOI:10.18632/oncotarget.26352] [PMID] [PMCID]

Kajimoto Y, Otsuki N, Teshima M, Morinaga Y, Itoh T, Nibu K-I. Successful Treatment of Interdigitating Dendritic Cell Sarcoma Presenting as Multiple Parotid Tumors. Acta Oto-Laryngologica Case Reports. 2019;4(1):26-9. [DOI:10.1080/23772484.2019.1635887]

Zhao C, Xie X, Gai DZ, Wu D, Xin H, Yang T. Interdigitating dendritic cell sarcoma of the spleen with hepatic failure after chemotherapy: A case report. Medicine (Baltimore). 2019;98(19):e15535. [DOI:10.1097/MD.0000000000015535] [PMID] [PMCID]

Madabhavi I, Patel A, Modi G, Anand A, Panchal H, Parikh S. Interdigitating dendritic cell tumor: A rare case report with review of literature. J Cancer Res Ther. 2018;14(3):690-3. [DOI:10.4103/0973-1482.183189] [PMID]

Wang HT, Xu HY, Zhang R, Liu ZG, Zhang GJ. Interdigitating dendritic cell sarcoma located in the groin: a case report and literature review. J Int Med Res. 2018;46(11):4791-9. [DOI:10.1177/0300060518792444] [PMID] [PMCID]

Sakakibara A, Takahashi E, Ishikawa E, Kohno K, Asano N, Nakamura S. Neoplastic PD-L1 expression on interdigitating dendritic cell sarcoma: A supplementary study of a case report. Pathol Int. 2018;68(10):577-8. [DOI:10.1111/pin.12711] [PMID]

Guerra F, Vegni A, Perna F, Messerini L, Coratti A. Primary jejunal interdigitating dendritic cell sarcoma. Ann Diagn Pathol. 2018;32:1-3. [DOI:10.1016/j.anndiagpath.2017.08.001] [PMID]

Hong KH, Song S, Shin W, Kang K, Cho C-S, Hong YT, et al. A case of interdigitating dendritic cell sarcoma studied by whole-exome sequencing. Genes & Genomics. 2018;40(12):1279-85. [DOI:10.1007/s13258-018-0724-y] [PMID]

Ninkovic S, Cole-Sinclair MF. Interdigitating dendritic cell sarcoma: diagnostic pitfalls, treatment challenges and role of transdifferentation in pathogenesis. Pathology. 2017;49(6):643-6. [DOI:10.1016/j.pathol.2017.05.015] [PMID]

Magro CM, Olson LC, Nuovo G, Solomon GJ. Primary cutaneous interdigitating dendritic cell sarcoma is a morphologic and phenotypic simulator of poorly differentiated metastatic melanoma: a report of 2 cases and review of the literature. Ann Diagn Pathol. 2017;30:59-65. [DOI:10.1016/j.anndiagpath.2017.02.008] [PMID]

Hwang SY, Woo IS, Chong Y, Kang CS, Han CW, Jung YH. An unusual case of metachronous NK/T cell lymphoma and interdigitating dendritic cell sarcoma. Blood Res. 2017;52(3):224-7. [DOI:10.5045/br.2017.52.3.224] [PMID] [PMCID]

Nguyen CM, Cassarino D. Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature. Am J Dermatopathol. 2016;38(8):628-31. [DOI:10.1097/DAD.0000000000000618] [PMID]

Lupato V, Romeo S, Franchi A, Mantovani M, Dei Tos AP, Tirelli G, et al. Head and Neck Extranodal Interdigitating Dendritic Cell Sarcoma: Case Report and Review of the Literature. Head Neck Pathol. 2016;10(2):145-51. [DOI:10.1007/s12105-015-0627-z] [PMID] [PMCID]

Hutter G, Hofer S, Tzankov A, Kothbauer KF. Intracranial Interdigitating Dendritic Cell Sarcoma: First Case Report. Neurosurgery. 2015;77(6):E979-83. [DOI:10.1227/NEU.0000000000000925] [PMID]

Shan SJ, Meng LH, Lu R, Guo Y. Primary Cutaneous Interdigitating Dendritic Cell Sarcoma: A Case Report and Review of the Literature. Am J Dermatopathol. 2015;37(8):639-42. [DOI:10.1097/DAD.0000000000000222] [PMID]

Di Liso E, Pennelli N, Lodovichetti G, Ghiotto C, Dei Tos AP, Conte P, et al. Braf mutation in interdigitating dendritic cell sarcoma: a case report and review of the literature. Cancer Biol Ther. 2015;16(8):1128-35. [DOI:10.1080/15384047.2015.1057359] [PMID] [PMCID]

O'Malley DP, Agrawal R, Grimm KE, Hummel J, Glazyrin A, Dim DC, et al. Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. Ann Diagn Pathol. 2015;19(3):113-6. [DOI:10.1016/j.anndiagpath.2015.02.008] [PMID]

Pokuri VK, Merzianu M, Gandhi S, Baqai J, Loree TR, Bhat S. Interdigitating dendritic cell sarcoma. J Natl Compr Canc Netw. 2015;13(2):128-32. [DOI:10.6004/jnccn.2015.0020] [PMID]

Helbig G, Wichary R, Pająk J, Budny M, Makowska M, Machura K, et al. Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma. Contemporary Oncol. 2015;19(1):83. [DOI:10.5114/wo.2014.43974] [PMID] [PMCID]

Lee S-y, Lee SR, Chang WJ, Kim HS, Kim BS, Kim IS. Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy. The Korean journal of hematology. 2012;47(2):150-3. [DOI:10.5045/kjh.2012.47.2.150] [PMID] [PMCID]

Uluoglu O, Akyurek N, Uner A, Coskun U, Ozdemir A, Gokcora N. Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement: a case report and review of the literature. Virchows Archiv : an international journal of pathology. 2005;446(5):546-54. [DOI:10.1007/s00428-005-1209-3] [PMID]

Lin P, Medeiros LJ. Hematopoietic Lesions. In: Gnepp DR, editor. Diagnostic Surgical Pathology of the Head and Neck. Philadelphia: W.B. Saunders; 2009. p. 933-74. [DOI:10.1016/B978-1-4160-2589-4.00013-9] [PMID]

O'Malley DP, Agrawal R, Grimm KE, Hummel J, Glazyrin A, Dim DC, et al. Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma. Annals of Diagnostic Pathology. 2015;19(3):113-6. [DOI:10.1016/j.anndiagpath.2015.02.008] [PMID]

Bailleux C, Robert G, Ginet C, Re D, Thyss A, Sudaka I, et al. Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib. Oncoscience. 2015;2(1):44-9. [DOI:10.18632/oncoscience.111] [PMID] [PMCID]

Peyrade F, Re D, Ginet C, Gastaud L, Allegra M, Ballotti R, et al. Low-dose vemurafenib induces complete remission in a case of hairy-cell leukemia with a V600E mutation. Haematologica. 2013;98(2):e20-2. [DOI:10.3324/haematol.2012.082404] [PMID] [PMCID]

Rosenberg SA, Niglio SA, Jo VY, Goydos JS. Interdigitating dendritic cell sarcoma presenting in the skin: diagnosis and the role of surgical resection, chemotherapy and radiotherapy in management. Rare tumors. 2014;6(4):5573. [DOI:10.4081/rt.2014.5573] [PMID] [PMCID]

Lee JC, Christensen T, OʼHara CJ. Metastatic Interdigitating Dendritic Cell Sarcoma Masquerading as a Skin Primary Tumor: A Case Report and Review of the Literature. Am J Dermatopathol. 2009;31(1):88-93. [DOI:10.1097/DAD.0b013e31818fb7e4] [PMID]